Recommendation on the technical and dosimetric data to be included in stereotactic body radiation therapy clinical trial publications based on a systematic review

Radiother Oncol. 2024 Jan:190:110042. doi: 10.1016/j.radonc.2023.110042. Epub 2023 Dec 1.

Abstract

The results of phase II and III trials on Stereotactic Body Radiation Therapy (SBRT) increased adoption of SBRT worldwide. The ability to replicate clinical trial outcomes in routine practice depends on the capability to reproduce technical and dosimetric procedures used in the clinical trial. In this systematic review, we evaluated if peer-reviewed publications of clinical trials in SBRT reported sufficient technical data to ensure safe and robust implementation in real world clinics. Twenty papers were selected for inclusion, and data was extracted by a working group of medical physicists created following the ESTRO 2021 physics workshop. A large variability in technical and dosimetric data were observed, with frequent lack of required information for reproducing trial procedures. None of the evaluated studies were judged completely reproducible from a technical perspective. A list of recommendations has been provided by the group, based on the analysis and consensus process, to ensure an adequate reproducibility of technical parameters in primary SBRT clinical trials. Future publications should consider these recommendations to assist transferability of the clinical trial in real world practice.

Keywords: Clinical trial; Reproducibility; SBRT; Treatment planning.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Humans
  • Radiometry
  • Radiosurgery* / methods
  • Radiotherapy Planning, Computer-Assisted / methods
  • Reproducibility of Results